Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -W-
02.09.2013 14:00:00

Strategic Collaborations, Acquisitions, Partnerships and Leadership Alignments - Research Report on Cigna, WellPoint, DaVita, Humana, and Mednax

NEW YORK, September 2, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Cigna Corp. (NYSE: CI), WellPoint Inc. (NYSE: WLP), DaVita, Inc. (NYSE: DVA), Humana Inc. (NYSE: HUM), and MEDNAX, Inc. (NYSE: MD). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Cigna Corp. Research Report

On August 26, 2013, Cigna Corp. (Cigna) and Saint Francis HealthCare Partners announced the launch of a collaborative accountable care initiative with effect from October 1, 2013,  to improve patient access to health care, enhance care coordination, and achieve the "triple aim" of improved health, affordability and patient experience. According to the Company, the program will benefit approximately 20,000 individuals covered by a Cigna health plan who receive care from Saint Francis HealthCare Partners. Robert Hockmuth, M.D., Cigna's Senior Medical Director for Connecticut said, "We want to fundamentally change the health care delivery system by rewarding physicians for results, A patient-centered system that's focused on prevention and wellness, combined with the right incentives for physicians, will ultimately result in a healthier population and lower medical costs. That's good for individuals, families, employers, doctors, and other healthcare providers." The Full Research Report on Cigna Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/7307_CI]

--

WellPoint Inc. Research Report

On August 19, 2013, WellPoint Inc. (WellPoint) announced that it will use CareNex's expertise in neonatal support internally, in association with the Company's care management services. Gail Borgatti Croall, MD, Senior Vice President of Care Management at WellPoint said, "Historically, across the health care delivery system, care for high-risk newborns has been far too fragmented and costly, We believe integrating CareNex's approach to coordinating care for the highest risk newborns as part of our goal to improve maternity-related care will offer our affiliated health plan members greater access to the support they need, when and where they need it most." According to the Company, CareNex partnered with WellPoint since 2009 and in December 2012 WellPoint acquired CareNex. The Full Research Report on WellPoint Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/64cd_WLP]

--

DaVita, Inc. Research Report  

On August 9, 2013, DaVita HealthCare Partners Inc. (DaVita) announced its long-planned mid-2014 transition of Robert Margolis, MD., out of his role as CEO of the HealthCare Partners Division (HCP). According to the Company, he will continue to serve as Co-Chairman of the Board of Directors, and will focus on business development, service enhancement, supporting HCP's management transition and future strategic projects. DaVita stated that Craig Samitt, M.D., has recently joined the Company as Executive Vice President of HCP and is expected to assume the position of CEO of its HCP, as a part of the planned transition, subject to board approval. Kent Thiry, CEO and Co-Chairman of DaVita said, "Bob has a long and distinguished history as the founder of HealthCare Partners. He has helped HCP become a national leader in coordinated care, patient-centered services and high-quality transparent results." The Full Research Report on DaVita, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/5986_DVA]

--

Humana Inc. Research Report

On August 27, 2013, Humana Inc. (Humana) announced that it has entered into a partnership with the YMCA of the USA (Y-USA) - a leading nonprofit organization, to educate individuals and families about health insurance and public exchange options that take effect in 2014 under the federal health care reform law. Roy A. Beveridge, M.D., Humana's Chief Medical Officer said, "The YMCA, known for strengthening communities across the country, is a highly trusted organization. Given the important need for education on health care reform, Humana's partnership with the Y helps provide people with information they can use to make well-informed decisions about their health coverage choices." Humana also informed that earlier this month it had announced its online strategy to educate individuals about health care reform. The Full Research Report on Humana Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/496b_HUM]

--

MEDNAX, Inc. Research Report

On August 5, 2013, Mednax, Inc. (Mednax) announced that it has acquired Holston Anesthesia Associates, P.C. According to the Company, this newly acquired physician group practice will now be a part of the Company's American Anesthesiology division and is the third Tennessee-based anesthesiology practice to join this division. Mark Carver, M.D., who will serve as Medical Director for the practice said,  "Joining American Anesthesiology will give us access to its proven infrastructure and facilitate collaboration with anesthesiologists nationwide through research education and quality initiatives, all while keeping our clinical autonomy. We are confident that this will result in even better patient care and outcomes, which is always our top priority." Mednax informed that as a result of the acquisition, seven physician group practices have become part of the Company in 2013, four as part of American Anesthesiology, and three as part of Pediatrix Medical Group. The Full Research Report on MEDNAX, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/671d_MD]

----

EDITOR NOTES:

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  • For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

  • COMPLIANCE PROCEDURE

    Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

    NOT FINANCIAL ADVICE

    Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

    NO WARRANTY OR LIABILITY ASSUMED

    Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

    AnalystsCorner.com


    SOURCE Analysts' Corner

    Analysen zu DaVita HealthCare Partners Incmehr Analysen

    Eintrag hinzufügen
    Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
    Es ist ein Fehler aufgetreten!

    Aktien in diesem Artikel

    DaVita HealthCare Partners Inc 156,00 2,13% DaVita HealthCare Partners Inc
    Humana Inc. 281,30 1,66% Humana Inc.
    Mednax Inc 13,80 1,47% Mednax Inc